Female professors are still underrepresented at Swiss universities. PRIMA is a funding instrument from the Swiss National Science Foundation (SNSF) that provides women with targeted support in their academic careers. Last year, funding was awarded to three female researchers at the University of Basel.
Labs and seminar rooms are empty, lectures are being held online. Even research has been reduced to the minimum. However, for Prof. Richard Neher from the University of Basel, these times are far from quiet. With his research on the global spread of the coronavirus, he is currently at the forefront of investigations into the pandemic.
Half a year into her new mandate as Personal Integrity Coordinator, Dr. Andrea Bauer takes stock for the first time. There has been a great demand for advice and support in the past few months, and there is still a lot more work to be done.
Much of the media coverage on COVID-19 focuses on numbers and statistics. While this can be helpful, it might also be overwhelming and confusing. How to decide how to act in the current situation? Social psychologists from the University of Basel recommend nine practical tips on how to make decisions now.
Currently, the question is being discussed whether taking the painkiller Ibuprofen exacerbates the progression of COVID-19. A correspondence by Basel researchers states that there are some indications of a negative effect, but no clear evidence of an adverse impact. More research is needed to investigate this hypothesis.
There will be no more classroom teaching at the University of Basel until the end of the spring semester 2020. In an interview, President Andrea Schenker-Wicki explains how the University of Basel is adapting to this situation.
Researchers of the University of Basel have developed a new method with which individual isolated molecules can be studied precisely – without destroying the molecule or even influencing its quantum state.
A new open online course, developed by the University of Basel in collaboration with the Swiss Academies of Arts and Sciences, will begin at the end of March. The six-week course focuses on interdisciplinary research and is freely accessible on the FutureLearn platform.
The University of Basel is part of the global search for a drug to fight the rampant coronavirus. Researchers in the Computational Pharmacy group have so far virtually tested almost 700 million substances, targeting a specific site on the virus – with the aim of inhibiting its multiplication. Due to the current emergency, the first results of the tests will be made available to other research groups immediately.
